Tekla Capital Management LLC - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 150 filers reported holding KURA ONCOLOGY INC in Q2 2023. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.

Quarter-by-quarter ownership
Tekla Capital Management LLC ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q1 2023$3,464,527
-1.5%
283,2810.0%0.13%
-0.8%
Q4 2022$3,515,517
-31.4%
283,281
+3.6%
0.13%
-19.4%
Q3 2021$5,122,000
-10.2%
273,4630.0%0.16%
-10.8%
Q2 2021$5,702,000
-26.2%
273,4630.0%0.18%
-30.5%
Q1 2021$7,731,000
-13.4%
273,4630.0%0.27%
-15.3%
Q4 2020$8,931,000
+391.3%
273,463
+360.8%
0.31%
+361.8%
Q3 2020$1,818,00059,3390.07%
Other shareholders
KURA ONCOLOGY INC shareholders Q2 2023
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,807,982$59,049,0006.41%
ACUTA CAPITAL PARTNERS, LLC 637,500$20,821,0005.67%
Asymmetry Capital Management, L.P. 346,518$11,317,0005.16%
Affinity Asset Advisors, LLC 260,000$8,492,0004.50%
EcoR1 Capital, LLC 1,773,037$57,907,0003.11%
VR Adviser, LLC 575,000$18,780,0002.76%
COMMODORE CAPITAL LP 133,503$4,360,0002.37%
Ghost Tree Capital, LLC 325,000$10,615,0002.36%
Avoro Capital Advisors LLC 4,000,000$130,640,0002.25%
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$2,939,0001.71%
View complete list of KURA ONCOLOGY INC shareholders